FDA Expands Use of Amgen ' s Blockbuster Drug FDA Expands Use of Amgen ' s Blockbuster Drug
Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer & Oncology | Food and Drug Administration (FDA) | Health | Hematology | Myeloma | Xgeva